300 related articles for article (PubMed ID: 30534175)
1. Severe refractory asthma: current treatment options and ongoing research.
Menzella F; Bertolini F; Biava M; Galeone C; Scelfo C; Caminati M
Drugs Context; 2018; 7():212561. PubMed ID: 30534175
[TBL] [Abstract][Full Text] [Related]
2. [Severe asthma revisited by biologic therapies emergences].
Guilleminault L; Didier A
Presse Med; 2019 Mar; 48(3 Pt 1):310-321. PubMed ID: 30922670
[TBL] [Abstract][Full Text] [Related]
3. Innovative treatments for severe refractory asthma: how to choose the right option for the right patient?
Menzella F; Galeone C; Bertolini F; Castagnetti C; Facciolongo N
J Asthma Allergy; 2017; 10():237-247. PubMed ID: 28919788
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and steroid-sparing effect of benralizumab: has it an advantage over its competitors?
Menzella F; Biava M; Bagnasco D; Galeone C; Simonazzi A; Ruggiero P; Facciolongo N
Drugs Context; 2019; 8():212580. PubMed ID: 31024635
[TBL] [Abstract][Full Text] [Related]
5. Anti-IL5 Therapies for Severe Eosinophilic Asthma: Literature Review and Practical Insights.
Menzella F; Ruggiero P; Ghidoni G; Fontana M; Bagnasco D; Livrieri F; Scelfo C; Facciolongo N
J Asthma Allergy; 2020; 13():301-313. PubMed ID: 32982318
[TBL] [Abstract][Full Text] [Related]
6. Reduction of oral corticosteroids in patients with severe eosinophilic asthma treated with Benralizumab: could it represent a marker of treatment efficacy?
Menzella F; Latorre M; Ruggiero P; Bagnasco D; Heffler E
Expert Opin Biol Ther; 2019 Jul; 19(7):601-606. PubMed ID: 31033373
[No Abstract] [Full Text] [Related]
7. Clinical implications of asthma endotypes and phenotypes.
Taunk ST; Cardet JC; Ledford DK
Allergy Asthma Proc; 2022 Sep; 43(5):375-382. PubMed ID: 36065106
[No Abstract] [Full Text] [Related]
8. Phenotypes and endotypes of uncontrolled severe asthma: new treatments.
Campo P; Rodríguez F; Sánchez-García S; Barranco P; Quirce S; Pérez-Francés C; Gómez-Torrijos E; Cárdenas R; Olaguibel JM; Delgado J; ;
J Investig Allergol Clin Immunol; 2013; 23(2):76-88; quiz 1 p. follow 88. PubMed ID: 23654073
[TBL] [Abstract][Full Text] [Related]
9. The Complex Type 2 Endotype in Allergy and Asthma: From Laboratory to Bedside.
Agache I; Sugita K; Morita H; Akdis M; Akdis CA
Curr Allergy Asthma Rep; 2015 Jun; 15(6):29. PubMed ID: 26141574
[TBL] [Abstract][Full Text] [Related]
10. Treatment of severe, uncontrolled eosinophilic asthma: Where we are heading.
Bernstein JA; Panettieri R
J Asthma; 2019 May; 56(5):459-472. PubMed ID: 29718738
[TBL] [Abstract][Full Text] [Related]
11. Use of biomarkers to identify phenotypes and endotypes of severeasthma.
Carr TF; Kraft M
Ann Allergy Asthma Immunol; 2018 Oct; 121(4):414-420. PubMed ID: 30059792
[TBL] [Abstract][Full Text] [Related]
12. Biologic Therapy and Novel Molecular Targets of Severe Asthma.
Pepper AN; Renz H; Casale TB; Garn H
J Allergy Clin Immunol Pract; 2017; 5(4):909-916. PubMed ID: 28689841
[TBL] [Abstract][Full Text] [Related]
13. A Case of Persistent Asthma Resistant to Available Treatment Options: Management Dilemma.
Ijaz HM; Chowdhury W; Lodhi MU; Gulzar Q; Rahim M
Cureus; 2019 Mar; 11(3):e4194. PubMed ID: 31106094
[TBL] [Abstract][Full Text] [Related]
14. Asthma phenotyping: a necessity for improved therapeutic precision and new targeted therapies.
Chung KF
J Intern Med; 2016 Feb; 279(2):192-204. PubMed ID: 26076339
[TBL] [Abstract][Full Text] [Related]
15. Blood Eosinophils as Biomarkers to Drive Treatment Choices in Asthma and COPD.
Kostikas K; Brindicci C; Patalano F
Curr Drug Targets; 2018; 19(16):1882-1896. PubMed ID: 29437007
[TBL] [Abstract][Full Text] [Related]
16. Increased serum IL-17A and Th2 cytokine levels in patients with severe uncontrolled asthma.
Hasegawa T; Uga H; Mori A; Kurata H
Eur Cytokine Netw; 2017 Mar; 28(1):8-18. PubMed ID: 28840844
[TBL] [Abstract][Full Text] [Related]
17. Revisiting Type 2-high and Type 2-low airway inflammation in asthma: current knowledge and therapeutic implications.
Robinson D; Humbert M; Buhl R; Cruz AA; Inoue H; Korom S; Hanania NA; Nair P
Clin Exp Allergy; 2017 Feb; 47(2):161-175. PubMed ID: 28036144
[TBL] [Abstract][Full Text] [Related]
18. The concepts of asthma endotypes and phenotypes to guide current and novel treatment strategies.
Ozdemir C; Kucuksezer UC; Akdis M; Akdis CA
Expert Rev Respir Med; 2018 Sep; 12(9):733-743. PubMed ID: 30084271
[TBL] [Abstract][Full Text] [Related]
19. Controversies and opportunities in severe asthma.
Humbert M; Busse W; Hanania NA
Curr Opin Pulm Med; 2018 Jan; 24(1):83-93. PubMed ID: 29059087
[TBL] [Abstract][Full Text] [Related]
20. Tailored interventions based on sputum eosinophils versus clinical symptoms for asthma in children and adults.
Petsky HL; Li A; Chang AB
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD005603. PubMed ID: 28837221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
